Koca, S. S. Et Al. 2021. DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES , vol.80 , 1317.

Koca, S. S., PEHLİVAN, Y., Akar, S., Senel, S., Karadeniz, H., Sosyal, O., ... Yazici, A.(2021). DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES , vol.80, 1317.

Koca, S. Et Al. "DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS," ANNALS OF THE RHEUMATIC DISEASES , vol.80, 1317, 2021

Koca, S. S. Et Al. "DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS." ANNALS OF THE RHEUMATIC DISEASES , vol.80, pp.1317, 2021

Koca, S. S. Et Al. (2021) . "DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS." ANNALS OF THE RHEUMATIC DISEASES , vol.80, p.1317.

@article{article, author={S. S. Koca Et Al. }, title={DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2021, pages={1317} }